Drug Profile
Rabacfosadine
Alternative Names: GS 9212; GS-9219Latest Information Update: 31 Dec 2010
Price :
$50
*
At a glance
- Originator Gilead Sciences
- Class Antineoplastics; Cyclopropanes; Nucleosides; Propylamines; Purines; Small molecules
- Mechanism of Action Apoptosis stimulants; DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Haematological malignancies
Most Recent Events
- 10 Dec 2010 Discontinued - Phase-I/II for Haematological malignancies in Czech Republic (IV)
- 10 Dec 2010 Discontinued - Phase-I/II for Haematological malignancies in Russia (IV)
- 10 Dec 2010 Discontinued - Phase-I/II for Haematological malignancies in USA (IV)